News PENBRAYA™ October 20, 2023 Read More » ZITUVIO October 20, 2023 Read More » CABTREO® October 20, 2023 Read More » GENERIC DRUG and BIOSIMILAR APPROVALS October 19, 2023 Read More » BIMZELX® October 18, 2023 Read More » VELSIPITY October 17, 2023 Read More » XPHOZAH October 17, 2023 Read More » ZILBRYSQ October 17, 2023 Read More » Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter October 2, 2023 Read More » Page1 … Page6 Page7 Page8 Page9 Page10 … Page45 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required) Email(Required) Comment(Required) Company Name(Required) CAPTCHA
Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter October 2, 2023 Read More »